🟢 Jagsonpal Pharmaceuticals is trading 5% up with no clear company-specific catalyst

Jagsonpal Pharmaceuticals is trading at INR 222.63, up 5.13%, with no clear company-specific announcement explaining the October 26 move. - The company had announced a board meeting to review quarterly results on October 28; the meeting is upcoming, not a reported results catalyst. - Broader support may have come from Indian pharma shares, with the Nifty Pharma among sectors leading the October 26 market recovery; this does not establish the specific cause of Jagsonpal’s gain.